CHECKIT
John Wilson
CEO
We have worked with Yellowstone Advisory for a number of years and they transformed our investor relations strategy which significantly increased the interest of our business to both institutional and retail investors. We have been impressed by their understanding of the smaller companies market and their results focussed approach to IR. I would recommend their services without hesitation.
​
EQUINITI
Guy Wakeley
CEO
Yellowstone Advisory provided valuable input into the interim results announcement and presentation, helping to ensure the investment messaging was consistent throughout the documents. Great relationships and credibility with investors enables them to solicit useful feedback which we have used in developing our future investor messaging.
​
​
.png){kind=small}
Oxford Biodynamics Private Investor Meeting - 10 Dec
Tue, 10 Dec
|City of London location. TBD
Hear Christian Hoyer Millar, CEO, Talk through the company strategy and progress since IPO
Time & Location
10 Dec 2019, 17:30 – 18:30
City of London location. TBD
Guests
About the event
Oxford Biodynamics is a revenue-generating biotechnology company focused on the discovery and development of novel biomarkers for use within the biotechnology and pharmaceutical industries. These biomarkers are based on the Chromosome Confirmation Signatures created from the way DNA is arranged in a 3D structure around Chromatin. It is these Chromosome Confirmation Signatures that cause many of the interactions that take place within a cell. What OBD have created is a quick and efficient technology for identifying these Chromosome Confirmation Signatures and what they indicate. This technology is called EpiSwitch and identifies very accurate Biomarkers.